Wednesday, 14 October 2020

Two Eli Lilly's COVID-19 studies testing remdesivir, experimental antibody therapy paused due to safety issues


via Firstpost Tech Latest News https://ift.tt/3iUMlXt

post written by:

Related Posts

0 comments: